According to a new report LAMEA Eye Health Supplements Market, published by KBV research, the LAMEA Eye Health Supplements Market would witness market growth of 11% CAGR during the forecast period (2020-2026).
The Brazil market dominated the LAMEA Antioxidants Market by Country in 2019, thereby, achieving a market value of $8.1 million by 2026. The Argentina market would witness a CAGR of 10.4% during (2020 - 2026). Additionally, The UAE market is exhibiting a CAGR of 9% during (2020 - 2026).
The Tablets market dominated the Saudi Arabia Eye Health Supplements Market by Formulation in 2019, growing at a CAGR of 9.3 % during the forecast period. The Capsules market is estimated to grow at a CAGR of 10.4% during (2020 - 2026). Additionally, The Others market is expected to witness highest CAGR of 16.5% during (2020 - 2026).
The Age-related Macular Degeneration (AMD) market dominated the South Africa Eye Health Supplements Market by Indication in 2019, growing at a CAGR of 10.3 % during the forecast period. The Dry Eye Syndrome market is experiencing a CAGR of 10.7% during (2020 - 2026). Additionally, The Inflammation market would showcase highest CAGR of 12.5% during (2020 - 2026).
Full Report: https://www.kbvresearch.com/lamea-eye-health-supplements-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of The Nature’s Bounty Co. (The Carlyle Group L.P.), Pfizer, Inc., Alticor Inc. (Amway Corporation), Novartis AG, Kemin Industries, Inc., ZeaVision LLC (EyePromise), EyeScience Labs, LLC, Vitabiotics Ltd., Nutrivein and NutraChamps, Inc.
By Formulation
By Indication
By Ingredient Type
By Country
Companies Profiled
Unique Offerings from KBV Research
Unique Offerings 
